[A pilot study on the impact of the drug resistance on the radioresistance in human pancreatic cancer cell lines]

Zhonghua Wai Ke Za Zhi. 2006 Jul 1;44(13):921-3.
[Article in Chinese]

Abstract

Objective: To investigate the impact of the drug resistance on the radioresistance in human pancreatic cancer cell lines.

Methods: Three drug resistant pancreatic cancer cell sublines induced by fluorouracil (5-FU), adriamycin (ADM) and gemcitabine respectively, SW1990/FU, SW1990/ADM and SW1990/Gz, were tested for the cell cycle and radio-sensitivity with flow cytometry and clonogenic assay.

Results: Compared with SW1990, the cell cycle assay indicated higher G(0)/G(1) period percentage in SW1990/FU and SW1990/Gz, but the G(2)/M period percentage decreased; SW1990/FU had the same while SW1990/Gz had lower S period percentage. SW1990/ADM almost had a similar cell cycle with SW1990. Clonogenic assay showed both SW1990/FU and SW1990/Gz had greater survival fraction (SF(2)) than SW1990, but SW1990/ADM had seemingly similar SF(2) as SW1990.

Conclusion: Drug resistant pancreatic cancer cell lines have reduced G(2)/M period percentage and increased radioresistance.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / pharmacology
  • Doxorubicin / pharmacology
  • Drug Resistance, Neoplasm / drug effects*
  • Drug Resistance, Neoplasm / genetics
  • Fluorouracil / pharmacology
  • Gemcitabine
  • Humans
  • Pancreatic Neoplasms / pathology*
  • Radiation Tolerance / drug effects*

Substances

  • Antineoplastic Agents
  • Deoxycytidine
  • Doxorubicin
  • Fluorouracil
  • Gemcitabine